A small start-up biotech firm anticipates that it will have cash outflows of \$ 200,000 per year at the end of the next 3 years. Then the firm expects a positive cash flow of \$ 50,000 at the EOY 4 and positive cash flows of \$ 250,000 at the EOY 5-9. Based on these estimates, Would you invest money in this company if your MARR is 15 \% per year? (all sections).